Strategic Partners provide the knowledge, critical skills and expertise to help you overcome hurdles and grow your business. They all offer competitive pricing on their products and services. Some offer discounts. Check this space frequently for the addition of new firms.
For More Information
1435 Walnut St., 4th Floor, Philadelphia, PA 19102 215-717-2777 | econsultsolutions.com
TechLink assists companies ranging in size from one-person startups to Global 100 corporations. Most have fewer than 100 employees. Through TechLink, companies and startups can access over 5,000 new DoD inventions, greatly leverage their R&D investments, and more successfully develop and commercialize new technologies. TechLink can also facilitate CRADAs for joint-research with the DoD.
TechLink Tech Managers assist companies to assess the above technologies and others posted to its searchable database — https://
TechLink, which creates high-value partnerships between the Department of Defense (DoD) and industry to develop, transfer and transition licensing and technologies. Its focus in medical and biotechnology research/inventions includes preventable and therapeutic vaccine treatments, antibodies, diagnostic tests, wound care products and health related software: https://
TechLink’s primary activity is marketing new inventions from Department of Defense labs and — at no cost — facilitating license agreements for these inventions, according to Yvonne Rudman, who will serve as NMBio’s primary contact to the organization.
TechLink helps companies to:
TechLink’s “Defense TechLink” program is DoD’s primary national partnership for technology transfer. DoD – the largest research entity in the world — has approximately 120 labs and research facilities nationwide, involving the Air Force, Army, Navy, and specialized agencies such as the National Security Agency. Defense TechLink has facilitated partnerships with most of these centers, linking them with private industry for technology licensing, transfer, and joint R&D.
Contract Research to Enable your Drug Development or Cell Therapy Program to Succeed
Being the first to market with your drug discovery is critical to healthcare outcomes, raising investment dollars, and market-share. Likarda’s services bridge the gaps in your research program or lab so you can move R&D forward confidently and quickly.
When you need drug development research support, but time and costs are limited, outsourcing to Likarda makes sense. Likarda is a proud supporter of NMBio (New Mexico Biotechnology and Biomedical Association). Current members of NMBio receive a minimum 5% discount on research services.
Support Well beyond Providing Data
But data is just data. We know there is far more to working with science entrepreneurs in the early discovery phase—such as passion and drive. Likarda’s team invests our expertise in you, taking time to understand your ultimate goals and customizing the research to meet them. Our only stake is in helping you succeed, not in ownership of your intellectual property.
Likarda performs human and veterinary drug discovery and development services in these areas:
LikardaOutsourcing CRO Work Offers Drug Discovery Research at Entrepreneurial Speed
Entrepreneurs and small pharmaceutical companies face demands and challenges from numerous directions. Data is needed to obtain financial support, submit strong patent applications, or strengthen a market strategy. Often the projects must be subdivided into smaller portions due to limited funding or access to the product.
Adept in projects big or small Likarda is a world-class, cutting-edge biotech research laboratory for science entrepreneurs. When you outsource CRO work to Likarda, we combine comprehensive research and development with consultative and analytical services so that you can move ahead in the drug development process with confidence, efficiency, and success at an affordable rate.
One Week in Our Time Is One Month in Traditional Lab TimeOutsourcing your CRO projects to Likarda, means you can bring products to market in a fraction of the time based on data we collect using a wide range of the same early-phase tests of large contract research organizations (CROs) such as:
Analytical ServicesWe provide several analytical services to further analyze your product or compounds including HPLC, mass spectrometry, method development, assay validation, environmental/photostability storage and testing, and spent media analysis (amino acid analysis).
Drug Discovery and ScreeningWe are dedicated specialists who listen to your needs and build a customized solution. Our experts in screening, profiling, and custom assay development, supplement your research team with support before, during, and after your testing. Our robotic and automated approach to high-throughput 3D compound screening and optimization helps you in early efficacy and toxicity screening, formulation optimization, and enables you to quickly get the data you need to make the most informed decisions about your drug development pathway or product pipelines.
MEDFAS founder Sam Macrina, after 44+ years of commercial banking experience, saw a need for national exposure to a U S Treasury economic development incentive which subsidizes the interest expense of a company’s expansion project. Under this program, the U S Treasury will pay up to $2.4 million of a company’s interest expense.
MEDFAS (Manufacturers Economic Development Financing Associates) was formed in 2013 to help Economic Development Professional and Bankers work together to create Jobs and increase economic development within their communities. Helping Manufacturers successfully access billions of dollars in Tax Advantage Financing, resulting in an average savings of 31% in interest expense alone. Offering personal and online training opportunities to help companies and economic development professionals understand and apply for Tax Advantage Financing.
Helping foreign and domestic manufacturers expand and invest: Low-cost capital access remains the primary strength of tax-exempt financing. Across the United States there are billions of dollars available every year for manufacturers to use to fund new projects and expansion plans.
Tax-Exempt Financing is a federally-authorized development finance tool that helps stimulate public and private investment including Foreign Direct Investment in the United States.
Tax-exempt financing is a broad term that also includes tax-exempt loans made by a bank or private lender to a private enterprise to finance the costs of capital projects. Tax-exempt financing is used for the purpose of investing in new facilities, production lines, machinery and equipment, and technological advancements that help bolster productivity and profit.
Tax-Exempt Financing may be used to fund the following assets:
Land: Includes acquisition, site preparation and improvements, infrastructure development (e.g., water, sewer & rail) and environmental testing.
Building: Includes acquisition, construction, rehabilitation, engineering, architectural, legal and other related costs.
Soft Costs: Includes legal, architectural, engineering, surveying, test boring, title insurance, appraisals, accounting and financing costs for the project.
Equipment: Includes acquisition, delivery and installation.
Company Acquisition: The acquisition of a manufacturing company structured as an asset purchase can be financed with tax-exempt debt.
Axcess Financial Group is committed to the belief that knowledge is the best insurance.
By acting not only as your insurance broker but also as an educator and consultant, we’ll help you master a more effective and efficient level of self-administration, so that you can focus on other important goals and objectives.
Serving business of all sizes and industries across the US, Axcess Financial Group is the most comprehensive Employee Benefits Advisory Firm in this market. Our local, on-site presence allows us to fully integrate with our clients in an effort to build a relationship with the employee population and monitor their changing perceptions of the benefits package.
Axcess Financial Group
Break away from the mold of the traditional broker. The average broker meets your basic needs when it comes to claims, plans and renewal negotiation. What about open enrollment? New legislation? The DOL?
From Technology Companies
New tech giants can be focused on curing the pains of HR such as benefits administration and small compliance issues, but lack the personal touch and insurance expertise that an independent broker like us provides
Point A Consulting is a strategic planning practice that focuses on technology-based economic development initiatives designed to strengthen and promote the knowledge economy assets of client communities. Spalding’s forte is integrating assessment of market opportunities with physical development strategies, to achieve place-based solutions as catalysts for growing regional innovation eco-systems.
His 30 years of experience includes leadership roles with research parks and technology incubators, as well as community-wide strategic planning initiatives. Since founding Point A Consulting in 2007, he has undertaken engagements related to strategic plans for innovation and technology-based economic development across the country, in partnership with leading urban design, technology commercialization and strategy consultancies. Point A Consulting member of the Association of University Research Parks (AURP)
Strategy & implementation for technology-based economic development for:
• Research Parks
• Incubators / Accelerators
• Innovation “Eco-systems” / Cluster Development
Universities, Regional Partnerships, Economic Development Organizations, Developers, Local & State Governments
For more information:
email Steven Spalding
or call 502-744-8115
Research park and incubator advisory services include:
Strategy & Positioning
Market & Technology Assessment
Best Practices in Governance, Marketing, Staffing, Financing, etc.
Stakeholder Engagement / Community Relations
Marketing and Communications Strategies
Implementation [Business] Plans
Interim Operations / Management
Real Estate Development / Public Private Partnership
AWS Bio-Pharma Technologies provides the highest quality, cost-effective solutions for the pharmaceutical and related manufacturing industries.
In addition, we possess strategic partnerships with other manufacturers of pharmaceutical equipment allowing us to provide quality, flexibility and value for a truly integrated solution. We focus on supporting our clients from the initial discussion, throughout installation, and through our continuous support long after the project has been completed.
AWS Bio-Pharms Technologies
(505) 259-8903 (m) Bruce@AWSBioPharma.com
We bring you effective processing solutions
ASEPTIC FILL-FINISH SYSTEMS
Our Aseptic Fill Finish Systems include Traditional Filling Lines, Isolated Filling Lines, Nested Filling Lines, Robotic Filling Lines and IV Bag Filling Lines.FULL FEATURES
ASEPTIC SUPPORT PROCESSING
Our Aseptic Support Processing Systems include Inspection/Leak-Testing Systems, IV Bag Processing Systems, SBM Processing Systems, FFS Processing Systems and Containment Systems.FULL FEATURES
Our Pharmaceutical Compounding Equipment includes CIP-SIP Systems, Mixing Systems, Robotic Systems, Tankage, Containment Systems and 503B Compounding Facilities.FULL FEATURES
Our Pharmaceutical Facilities include Modular Cleanroom Systems, Water Purification Systems, Decontamination Facility Systems (Biowaste, Washing) and Turn-key Systems.FULL FEATURES
We turn non-dilutive funding into a strategic source of funding for life science organizations
Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. We assist in maximizing potential to receive funding from non-dilutive sources such as the NIH, DOD, NSF, FDA, BARDA, etc., as well as Private Foundations.
FreeMind’s knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award.
FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.
Ayal Ronen, VP
Creative Strategies for Economic Development Organizations & Assets
Sean O’Shea, MBA
Founder & President
3900 Paseo del Sol
Santa Fe, NM 87507
505-699-4229 | email@example.com
HatchForm creates programs and strategies for economic development organizations and assets.
1. Business Incubators & Accelerators
HatchForm assists Business Incubators, Accelerators and other entrepreneur focused economic development assets like Innovation Hubs, Maker Spaces, Tech Transfer Offices etc. create or update their client centric strategies and organizational value propositions. HatchForm also leads strategic forums, conducts market and community supply analysis, and completes feasibility studies for future Business Incubators or other proposed assets
2. Economic Development Organizations
HatchForm helps EDO’s refine their strategic approach to community wealth creation through targeted, impactful, and sustainable tactical programming. EDO assistance includes creating programs like BR&E, Cluster Analysis and Implementation, EcoSystem and Asset Mapping, etc. HatchForm also uses it’s own approach based on the Three Horizon Framework to create strategies around base, emerging, and embryonic industries within each community. HatchForm believes that focused, innovative and metric driven programs are a cornerstone of any organization’s strategic implementation.
Using methods pioneered at the Agile Strategy Lab incorporated with our own tools like the Economic Development Strategy Canvas, HatchForm helps communities create strategies that can be immediately implemented and won’t just collect dust on the city manger’s shelf.